Diagnos Inc.
ADK.V
TSX
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 12.05% | -38.06% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 12.05% | -38.06% | |||
| Cost of Revenue | -6.16% | 149.08% | |||
| Gross Profit | 7.58% | -226.11% | |||
| SG&A Expenses | 31.08% | 21.10% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 18.20% | 47.25% | |||
| Operating Income | -18.36% | -52.66% | |||
| Income Before Tax | -15.96% | -42.72% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -15.96% | -42.72% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -15.96% | -42.72% | |||
| EBIT | -18.36% | -52.66% | |||
| EBITDA | -19.07% | -55.66% | |||
| EPS Basic | -1.10% | -35.82% | |||
| Normalized Basic EPS | -1.75% | -35.71% | |||
| EPS Diluted | -1.10% | -35.82% | |||
| Normalized Diluted EPS | -1.75% | -35.71% | |||
| Average Basic Shares Outstanding | 13.81% | 5.61% | |||
| Average Diluted Shares Outstanding | 13.81% | 5.61% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
